Astra Pharmaceutical Products, Inc. v. Occupational Safety & Health Review Commission

681 F.2d 69, 10 Fed. R. Serv. 1087, 10 OSHC (BNA) 1697, 1982 U.S. App. LEXIS 18065
CourtCourt of Appeals for the First Circuit
DecidedJune 22, 1982
DocketNo. 81-1672
StatusPublished
Cited by2 cases

This text of 681 F.2d 69 (Astra Pharmaceutical Products, Inc. v. Occupational Safety & Health Review Commission) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Astra Pharmaceutical Products, Inc. v. Occupational Safety & Health Review Commission, 681 F.2d 69, 10 Fed. R. Serv. 1087, 10 OSHC (BNA) 1697, 1982 U.S. App. LEXIS 18065 (1st Cir. 1982).

Opinion

LEVIN H. CAMPBELL, Circuit Judge.

Astra Pharmaceutical Products, Inc. (“Astra”) appeals from a decision of the Occupational Safety and Health Review Commission (OSHRC) pursuant to 29 U.S.C. § 660(a). The Commission found Astra in violation of 29 C.F.R. § 1910.132(a)1 for [71]*71failure to see that one of its employees, Paul Sund, was using certain items of protective equipment when a chemical vat at which he was working overflowed, seriously injuring him.

A one-day hearing was conducted on the matter by an administrative law judge (ALJ). At that hearing the Secretary of Labor presented two witnesses: an Occupational Safety and Health Administration Inspector, Mr. Goyda, who inspected the Astra plant in Worcester, Massachusetts on the day following the accident, and a Mr. Ratner, an expert industrial hygienist with OSHA who had never visited the Astra facility. Astra offered no evidence of its own.

The Secretary’s witnesses, particularly Mr. Goyda, established that an accident had occurred at the Worcester plant on November 7, 1978, when a vat used in the production of chloroacetyl xylidine (an intermediate chemical in the production of the anesthetic Xylocaine — an Astra product) overflowed, spraying toxic chemicals2 in the immediate area. Paul Sund, an Astra employee of 20 years’ experience who was tending the vat, was in the area at the time and was subsequently hospitalized as result of the overflow.

Mr. Goyda arrived at the Astra plant the following day to make his inspection. In the course of his investigation he spoke with several employees who had helped to wash Sund with water after the accident. Goyda testified particularly to a conversation with a Mr. Carlson — one of Sund’s fellow employees. Goyda’s testimony on direct examination — which was characterized as hearsay by the ALJ — -was as follows:

Q. Did he [Mr. Carlson] relate to you his observation of Mr. Sund on November 7, 1978, immediately after this so-called accident occurred?
A. Yes, he did.
Q. What did he tell you?
A. That Mr. Sund was covered with chemical from head to toe.
Q. Where did he see Mr. Sund, do you know?
A. They had come back — I think he saw him coming down the steps from the room containing the reactor vessel involved in the accident.
Q. So the reactor is on the second floor of this building?
A. Yes.
Q. And what happened then? What did Mr. Carlson say happened at that point?
A. They started administering Mr. Sund.
Q. In what way?
A. Cleaning him off with water, showering him.
Q. Did he tell you where this chemical material was on Mr. Sund’s body?
A. Completely covered.
Q. Did this include his head?
A. Yes.
Q. Did this include his mouth area?
A. Yes.

Mr. Goyda also spoke with a Mr. Mandel-la, Paul Sund’s supervisor, regarding the type of protective equipment normally used by Paul Sund. Goyda’s testimony regarding what Mr. Mandella told him was as follows:

Q. Did you discuss the wearing of a [sic] personal protective equipment with Mr. Mandella?
A. Yes.
[72]*72Q. What did he tell you with respect to the Company’s policy, if any, with respect to the wearing of personal protective equipment by Mr. Sund while he’s engaged in producing this product which you have described?
A. He explained the personal protective equipment that was worn in that area.
Q. What was that personal protective equipment?
MR. LeDOUX. Objection. Is the question what was it or what did Mr. Mandella tell him?
Q. What did Mr. Mandella tell you about personal protective equipment being worn in the area?
A. He explained that during certain phases of the operation, a respirator, chemical goggles, and gloves were worn.
Q. Were these provided by the Company?
A. Yes, I would assume so.[3]

The Secretary also demonstrated through its two witnesses and various exhibits that Astra was aware that the chemicals involved in the accident were hazardous and that “full body protection” — including, according to both Mr. Goyda and Mr. Ratner, boots, jacket, pants and a full face shield all impervious to the chemicals — would have been the appropriate protection required under industry standards.4 As previously noted, Astra chose to put on no evidence to rebut the Secretary’s case.

After all the evidence was in, the ALJ issued a decision in which he vacated the Secretary’s 29 C.F.R. § 1910.132(a) citation and proposed $800 penalty on the grounds that no evidence had been submitted of what Sund was actually wearing at the time of the accident. The ALJ pointed out that neither supervisor Mandella nor employee Carlson were called as witnesses5 and was of the view that, without their testimony, “the allegation that Astra did not require employees to use protective clothing when needed [is] unsupported.” The ALJ’s decision was then appealed to the Review Commission by the Secretary. The Commission reversed, stating,

Mandella’s statement [to Goyda] regarding Astra’s personal protective equipment policy, having been specifically limited to a respirator, goggles, and gloves, is probative evidence from which we find that the injured employee (Sund) used no greater protection while making chloroa-cetyl xylidine.

This appeal followed with Astra’s argument pitched essentially on the same grounds as was the ALJ’s opinion.

Our review of the Commission’s decision is a narrow one especially where, as here, the chief dispute on appeal is factual. We will affirm the Commission’s decision so long as it is supported by “substantial evidence on the record considered as a whole.” 29 U.S.C. § 660(a). See General Dynamics v. OSHRC, 599 F.2d 453, 464 (1st Cir. 1979). “Substantial evidence” means “such relevant evidence as a reasonable mind might accept as adequate to support a conclusion,” Universal Camera Corp. v. NLRB, 340 U.S. 474, 477, 71 S.Ct. 456, 459, 95 L.Ed. 456 (1951), quoting Consolidated Edison Co. v. NLRB, 305 U.S. 197

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
681 F.2d 69, 10 Fed. R. Serv. 1087, 10 OSHC (BNA) 1697, 1982 U.S. App. LEXIS 18065, Counsel Stack Legal Research, https://law.counselstack.com/opinion/astra-pharmaceutical-products-inc-v-occupational-safety-health-review-ca1-1982.